Swiss National Bank Organogenesis Holdings Inc. Transaction History

Swiss National Bank

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 08, 2023	BUY	$2.34 - $4.43 $371,358 - $703,041	158,700 New	158,700 $504,000
Q1 2023 May 10, 2023	SELL	$1.89 - $2.93 $17,577 - $27,249	-9,300 Reduced 6.82%	127,100 $270,000
Q2 2022 Aug 09, 2022	BUY	$4.74 - $8.15 $285,822 - $491,445	60,300 Added 79.24%	136,400 $666,000
Q1 2022 May 09, 2022	BUY	$6.47 - $9.57 $36,232 - $53,592	5,600 Added 7.94%	76,100 $580,000
Q2 2021 Aug 06, 2021	BUY	$14.92 - $23.23 $1.05 Million - $1.64 Million	70,500 New	70,500 $1.17 Million

117

63.2M

25K

23.2K

Ticker ORGO
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 130,888,000
Market Cap $505M
Description
Organogenesis Holdings Inc., a regenerative medicine company develops, manufactures, and commercializes solutions for the advanced wound care, and surgical and sports medicine markets in the United States. The company's advanced wound care products include Affinity, an amniotic membrane wound covering in which viable cells growth factors/cytokin...

Get notified when there are updates to the investment portfolio of Swiss National Bank, based on Form 13F filings with the SEC.

Stay updated on Swiss National Bank with notifications on news.